Submitted:
14 June 2024
Posted:
17 June 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3.1. Data Acquisition in the NFP Group
3.2. Data Acquisition in the LMH Group
3.3. Statistical Analysis
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Taşlıpınar Uzel AG, Gelisken F, Kühlewein L, Neubauer J. VOLUMETRIC ANALYSIS OF LAMELLAR MACULAR HOLE: An Optical Coherence Tomography Study. Retina. 2023 Feb 1;43(2):209–14.
- Pi S, Hormel TT, Wang B, Bailey ST, Hwang TS, Huang D, et al. Volume-based, layer-independent, disease-agnostic detection of abnormal retinal reflectivity, nonperfusion, and neovascularization using structural and angiographic OCT. Biomed Opt Express, BOE. 2022 Sep 1;13(9):4889–906. [CrossRef]
- El Habib Daho M, Li Y, Zeghlache R, Boité HL, Deman P, Borderie L, et al. DISCOVER: 2-D multiview summarization of Optical Coherence Tomography Angiography for automatic diabetic retinopathy diagnosis. Artif Intell Med. 2024 Mar;149:102803.
- Nipp GE, Sarici K, Lee T, Hadziahmetovic M. Risk factors for worsening morphology and visual acuity in eyes with adult-onset foveomacular vitelliform dystrophy. Ophthalmol Retina. 2024 Mar 8;S2468-6530(24)00108-8. [CrossRef]
- von der Burchard C, Treumer F, Ehlken C, Koinzer S, Purtskhvanidze K, Tode J, et al. Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD. Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1623–9. [CrossRef]
- Guo Y, Hormel TT, Xiong H, Wang J, Hwang TS, Jia Y. Automated Segmentation of Retinal Fluid Volumes From Structural and Angiographic Optical Coherence Tomography Using Deep Learning. Transl Vis Sci Technol. 2020 Oct;9(2):54.
- Balk LJ, Coric D, Knier B, Zimmermann HG, Behbehani R, Alroughani R, et al. Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019 Jul 1;5(3):2055217319871582.
- Nam KT, Yun C, Lee YJ, Choi M, Kang D, Oh J. Visual Outcome and Fluid Changes Between Eyes With Polypoidal Choroidal Vasculopathy Receiving Biosimilar CKD-701 or Reference Ranibizumab Therapy: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial. Curr Eye Res. 2024 Mar 7;1–8.
- Schmidt-Erfurth U, Mulyukov Z, Gerendas BSS, Margaron P, Lorand D, Bogunovic H, et al. A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis. Investigative Ophthalmology & Visual Science. 2020 Jun 10;61(7):1159.
- Waldstein SM, Philip AM, Leitner R, Simader C, Langs G, Gerendas BS, et al. Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2016 Feb;134(2):182–90. [CrossRef]
- Lee H, Jo A, Kim HC. Three-Dimensional Analysis of Morphologic Changes and Visual Outcomes in Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1337–45. [CrossRef]
- Rommel F, Brinkmann MP, Sochurek JAM, Prasuhn M, Grisanti S, Ranjbar M. Ocular Blood Flow Changes Impact Visual Acuity Gain after Surgical Treatment for Idiopathic Epiretinal Membrane. J Clin Med. 2020 Jun 7;9(6):1768. [CrossRef]
- Aumann S, Donner S, Fischer J, Müller F. Optical Coherence Tomography (OCT): Principle and Technical Realization. In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet]. Cham: Springer International Publishing; 2019 [cited 2024 Mar 22]. p. 59–85. Available from: . [CrossRef]
- Zeppieri M, Marsili S, Enaholo ES, Shuaibu AO, Uwagboe N, Salati C, et al. Optical Coherence Tomography (OCT): A Brief Look at the Uses and Technological Evolution of Ophthalmology. Medicina (Kaunas). 2023 Dec 3;59(12):2114.
- Tian J, Varga B, Tatrai E, Fanni P, Somfai GM, Smiddy WE, et al. Performance evaluation of automated segmentation software on optical coherence tomography volume data. J Biophotonics. 2016 May;9(5):478–89.
- Debuc D. A Review of Algorithms for Segmentation of Retinal Image Data Using Optical Coherence Tomography. In: Image Segmentation. 2011.
- Schlegl T, Waldstein SM, Bogunovic H, Endstraßer F, Sadeghipour A, Philip AM, et al. Fully Automated Detection and Quantification of Macular Fluid in OCT Using Deep Learning. Ophthalmology. 2018 Apr;125(4):549–58. [CrossRef]
- Li MX, Yu SQ, Zhang W, Zhou H, Xu X, Qian TW, et al. Segmentation of retinal fluid based on deep learning: application of three-dimensional fully convolutional neural networks in optical coherence tomography images. Int J Ophthalmol. 2019;12(6):1012–20. [CrossRef]
- Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform. 2017 May 6;19(6):1236–46.
- Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS, et al. Optical coherence tomography-based consensus definition for lamellar macular hole. Br J Ophthalmol. 2020 Dec;104(12):1741–7.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307–10.
- Mj L, Wh Z, Yx L, Hz M, Yc L, Mh J. Sample Size for Assessing Agreement between Two Methods of Measurement by Bland-Altman Method. The international journal of biostatistics [Internet]. 2016 Jan 11 [cited 2024 May 25];12(2). Available from: https://pubmed.ncbi.nlm.nih.gov/27838682/.
- Verticchio Vercellin AC, Jassim F, Poon LYC, Tsikata E, Braaf B, Shah S, et al. Diagnostic Capability of Three-Dimensional Macular Parameters for Glaucoma Using Optical Coherence Tomography Volume Scans. Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4998–5010.
- Kaiser PK, Wykoff CC, Singh RP, Khanani AM, Do DV, Patel H, et al. RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2021 Aug;41(8):1579–86. [CrossRef]
- Schneider M, Bjerager J, Hodzic-Hadzibegovic D, Klefter ON, Subhi Y, Hajari J. Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2024 Feb 28; [CrossRef]
- Jiang X, Shen M, Wang L, de Sisternes L, Durbin MK, Feuer W, et al. Validation of a Novel Automated Algorithm to Measure Drusen Volume and Area Using Swept Source Optical Coherence Tomography Angiography. Transl Vis Sci Technol. 2021 Apr 14;10(4):11. [CrossRef]
- Hsiao CH, Sun TL, Lin PC, Peng TY, Chen YH, Cheng CY, et al. A deep learning-based precision volume calculation approach for kidney and tumor segmentation on computed tomography images. Computer Methods and Programs in Biomedicine. 2022 Jun 1;221:106861. [CrossRef]
- Bai F, Marques MJ, Gibson SJ. Cystoid macular edema segmentation of Optical Coherence Tomography images using fully convolutional neural networks and fully connected CRFs [Internet]. arXiv; 2017 [cited 2024 Jan 13]. Available from: http://arxiv.org/abs/1709.05324.
- Guo S, Tutela AC, Wagner R, Caputo AR. A comparison of the effectiveness of four biostains in enhancing visualization of the vitreous. J Pediatr Ophthalmol Strabismus. 2006 Oct;43(5):281–4. [CrossRef]





| Type of comparison | n | Estimate of Bias (mm) | 95% CI (mm) | Lower Limit of agreement (mm) | 95% CI (mm) | Upper Limit of agreement (mm) | 95% CI (mm) | Coefficient of Repeatability (mm) |
|---|---|---|---|---|---|---|---|---|
| Intraobserver Total Retinal Volume | ||||||||
| Obs 1, Obs 1 | 30 | 0.0074 | 0.0048 to 0.0100 | -0.0067 | -0.0144 to 0.0010 | 0.0215 | 0.0138 to 0.0292 | 0.0141 |
| Obs 2, Obs 2 | 30 | 0.0066 | 0.0042 to 0.0090 | -0.0066 | -0.0139 to 0.0006 | 0.0198 | 0.0125 to 0.0270 | 0.0132 |
| Interobserver Total Retinal Volume | ||||||||
| Obs 1 - Obs 2 | 30 | -0.0021 | -0.0041 to -0.0001 | -0.0132 | -0.0193 to -0.0071 | 0.0090 | 0.0029 to 0.0151 | 0.0111 |
| Automated – Obs 1 | 30 | -0.0041 | -0.0067 to -0.0015 | -0.0184 | -0.0262 to -0.0106 | 0.0102 | 0.0024 to 0.0180 | 0.0143 |
| Automated – Obs 2 | 30 | -0.0062 | -0.0088 to -0.0036 | -0.0203 | -0.0280 to -0.0126 | 0.0079 | 0.0002 to 0.0156 | 0.0141 |
| Intraobserver Foveal Cavity | ||||||||
| Obs 1, Obs 1 | 32 | -0.0021 | -0.0061 to 0.0020 | -0.0242 | -0.0359 to -0.0125 | 0.0201 | 0.0083 to 0.0318 | 0.0221 |
| Obs 2, Obs 2 | 32 | -0.0048 | -0.0080 to -0.0016 | -0.0222 | -0.0315 to -0.0130 | 0.0126 | 0.0034 to 0.0219 | 0.0174 |
| Interobserver Foveal Cavity | ||||||||
| Obs 1, Obs 2 | 32 | -0.0004 | -0.0020 to 0.0011 | -0.0088 | -0.0132 to -0.0043 | 0.0079 | 0.0035 to 0.0123 | 0.0083 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).